Jack Hall

853 total citations
17 papers, 379 citations indexed

About

Jack Hall is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Jack Hall has authored 17 papers receiving a total of 379 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Surgery, 8 papers in Pulmonary and Respiratory Medicine and 5 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Jack Hall's work include Coronary Interventions and Diagnostics (9 papers), Cerebrovascular and Carotid Artery Diseases (6 papers) and Cardiac Imaging and Diagnostics (5 papers). Jack Hall is often cited by papers focused on Coronary Interventions and Diagnostics (9 papers), Cerebrovascular and Carotid Artery Diseases (6 papers) and Cardiac Imaging and Diagnostics (5 papers). Jack Hall collaborates with scholars based in United States, United Kingdom and New Zealand. Jack Hall's co-authors include N L Browse, Tift Mann, John A. Ormiston, Louis Cannon, Lazar Mandinov, Mark Turco, Jeffrey J. Popma, Donald S. Baim, Mark Webster and Thomas McGarry and has published in prestigious journals such as The Lancet, Circulation and Journal of the American College of Cardiology.

In The Last Decade

Jack Hall

16 papers receiving 340 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jack Hall United States 9 282 235 118 90 65 17 379
Thaddeus R. Tolleson United States 8 410 1.5× 432 1.8× 108 0.9× 128 1.4× 69 1.1× 14 543
Louise Gambone United States 6 321 1.1× 436 1.9× 83 0.7× 119 1.3× 107 1.6× 10 562
Alberto Benassi Italy 12 349 1.2× 366 1.6× 97 0.8× 146 1.6× 43 0.7× 20 473
Matthew J. Mick United States 9 267 0.9× 618 2.6× 121 1.0× 63 0.7× 132 2.0× 9 707
Christopher J. White United States 9 459 1.6× 513 2.2× 83 0.7× 136 1.5× 134 2.1× 12 679
Cynthia Senerchia United States 9 545 1.9× 426 1.8× 304 2.6× 144 1.6× 44 0.7× 14 609
Girish Mood United States 6 435 1.5× 359 1.5× 103 0.9× 108 1.2× 18 0.3× 8 502
Mauro Pennacchi Italy 9 228 0.8× 199 0.8× 114 1.0× 64 0.7× 14 0.2× 26 321
Javed Suleman United States 10 313 1.1× 359 1.5× 95 0.8× 172 1.9× 39 0.6× 24 532
Antonella Scalone Italy 7 490 1.7× 574 2.4× 63 0.5× 47 0.5× 47 0.7× 7 629

Countries citing papers authored by Jack Hall

Since Specialization
Citations

This map shows the geographic impact of Jack Hall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jack Hall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jack Hall more than expected).

Fields of papers citing papers by Jack Hall

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jack Hall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jack Hall. The network helps show where Jack Hall may publish in the future.

Co-authorship network of co-authors of Jack Hall

This figure shows the co-authorship network connecting the top 25 collaborators of Jack Hall. A scholar is included among the top collaborators of Jack Hall based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jack Hall. Jack Hall is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Bradbury, Andrew W., Jack Hall, Matthew Popplewell, et al.. (2025). Plain versus drug balloon and stenting in severe ischaemia of the leg (BASIL-3): open label, three arm, randomised, multicentre, phase 3 trial. BMJ. 388. e080881–e080881. 6 indexed citations
3.
Hemming, Karla, Jack Hall, Andrew Copas, et al.. (2025). Covariate adjustment in cluster randomised trials: a practical guide. BMJ. 391. e084194–e084194.
5.
Moakes, Catherine A, Andrew W. Bradbury, Gareth Bate, et al.. (2024). Vein bypass first vs. best endovascular treatment first revascularisation strategy for chronic limb-threatening ischaemia due to infra-popliteal disease: the BASIL-2 RCT. Health Technology Assessment. 28(65). 1–72. 1 indexed citations
6.
Hall, Jack, et al.. (2023). Skeletal muscle index is associated with long term outcomes after lobectomy for non-small cell lung cancer. BMC Cancer. 23(1). 778–778. 6 indexed citations
7.
Meredith, Ian T., Paul S. Teirstein, Alain Bouchard, et al.. (2014). Three-Year Results Comparing Platinum-Chromium PROMUS Element and Cobalt-Chromium XIENCE V Everolimus-Eluting Stents in De Novo Coronary Artery Narrowing (from the PLATINUM Trial). The American Journal of Cardiology. 113(7). 1117–1123. 29 indexed citations
8.
Stone, Gregg W., Paul Teirstein, Ian T. Meredith, et al.. (2012). TWO-YEAR RESULTS OF THE PLATINUM RANDOMIZED TRIAL COMPARING PLATINUM CHROMIUM PROMUS ELEMENT AND COBALT CHROMIUM PROMUS/XIENCE V EVEROLIMUS-ELUTING STENTS IN DE NOVO CORONARY ARTERY LESIONS. Journal of the American College of Cardiology. 59(13). E323–E323. 5 indexed citations
10.
Weissman, Neil J., Mark Turco, John A. Ormiston, et al.. (2010). Improved strut coverage and less late incomplete apposition with thin-strut TAXUS Liberté vs. TAXUS Express: the importance of stent platform design for drug-eluting stents. Cardiovascular revascularization medicine. 12(4). 247–257. 9 indexed citations
11.
Mahmud, Ehtisham, John A. Ormiston, Mark Turco, et al.. (2009). TAXUS Liberté Attenuates the Risk of Restenosis in Patients With Medically Treated Diabetes Mellitus. JACC: Cardiovascular Interventions. 2(3). 240–252. 27 indexed citations
12.
Ormiston, John A., Ehtisham Mahmud, Mark Turco, et al.. (2008). Direct Stenting With the TAXUS Liberté Drug-Eluting Stent. JACC: Cardiovascular Interventions. 1(2). 150–160. 23 indexed citations
13.
Turco, Mark, John A. Ormiston, Jeffrey J. Popma, et al.. (2008). Reduced Risk of Restenosis in Small Vessels and Reduced Risk of Myocardial Infarction in Long Lesions With the New Thin-Strut TAXUS Liberté Stent. JACC: Cardiovascular Interventions. 1(6). 699–709. 67 indexed citations
14.
Turco, Mark, John A. Ormiston, Jeffrey J. Popma, et al.. (2007). Polymer-Based, Paclitaxel-Eluting TAXUS Liberté Stent in De Novo Lesions. Journal of the American College of Cardiology. 49(16). 1676–1683. 81 indexed citations
15.
Turco, Mark, John A. Ormiston, Jeffrey J. Popma, et al.. (2007). Abstract 2153: Taxus Atlas Long Lesion: First Report of 9-Month Clinical and Angiographic Outcomes for the TAXUS Liberte 38 mm Stent for Long Lesions. Circulation. 116(suppl_16). 1 indexed citations
16.
Hull, Russell D., Gary E. Raskob, Graham F. Pineo, et al.. (1992). Subcutaneous Low-Molecular-Weight Heparin Compared With Continuous Intravenous Heparin in the Treatment of Proximal-Vein Thrombosis. Obstetrical & Gynecological Survey. 47(9). 620–622. 48 indexed citations
17.
Browse, N L & Jack Hall. (1969). EFFECT OF DIPYRIDAMOLE ON THE INCIDENCE OF CLINICALLY DETECTABLE DEEP-VEIN THROMBOSIS. The Lancet. 294(7623). 718–721. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026